Search results
Sarepta Therapeutics gains as Pfizer failure removes overhang By Investing.com
Investing.com· 2 days agoSarepta Therapeutics (NASDAQ:SRPT) stock rose over 3% Thursday after Pfizer (NYSE:PFE) announced...
UPDATE: Pfizer's phase 3 gene therapy trial fails to improve function for boys with Duchenne...
FierceBiotech· 3 days agoPfizer’s phase 3 gene therapy trial has failed to demonstrate significant improvement in motor...
Pfizer (PFE) Phase III DMD Gene Therapy Study Misses Goal
Zacks· 2 days agoFree Report) announced that a phase III study on its mini-dystrophin gene therapy fordadistrogene movaparvovec for treating Duchenne muscular dystrophy (“DMD”) failed to meet the primary endpoint ...
Market Today: Boeing Delays 737 Production, Pfizer Extends Losse
Guru Focus· 14 hours agoMarket Performance Overview The S&P 500 and Nasdaq Composite hit fresh record highs this week,...
Pfizer's gene-therapy trial failure boosts Sarepta's stock
Morningstar· 2 days agoShares of Sarepta Therapeutics Inc. (SRPT) gained 4% premarket on Thursday after a potential competitor to its gene therapy stumbled in a late-stage trial. Pfizer Inc. said ...
Pfizer's Duchenne gene therapy fails in late-stage study
Reuters· 3 days agoThe therapy also did not show a significant difference compared to placebo in secondary goals of the...
Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds
FOX Business· 7 days agoA 15-day course of Pfizer's COVID-19 antiviral treatment Paxlovid did not relieve symptoms of long...
Pentagon ran secret anti-vax campaign to undermine China during pandemic
Fox News· 16 hours agoAt the height of the COVID-19 pandemic, the U.S. military launched a secret campaign to counter what...
Pfizer study finds Paxlovid ineffective against Long COVID despite federal research funds
22 WSBT South Bend· 3 days agoLong COVID is a chronic condition resulting from an initial infective with COVID-19, according to...
Sarepta’s stock gains after Pfizer’s Duchenne trial failure - Boston Business Journal
The Business Journals· 2 days agoPharma giant Pfizer Inc. (NYSE: PFE) announced on Wednesday after markets closed that its gene...